tailieunhanh - Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats

Preventing pulmonary vascular remodeling is a key strategy for pulmonary hypertension (PH). Causes of PH include pulmonary vasoconstriction and inflammation. This study aimed to determine whether cilostazol (CLZ), a phosphodiesterase-3 inhibitor, prevents monocrotaline (MCT)- and chronic hypoxia (CH)-induced PH development in rats. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN